ArticleFuture oncology (London, England)2025

LIVER-R study protocol: a global real-world study of durvalumab-based regimens in patients with hepatobiliary cancers.

Masafumi Ikeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.